>10%: Gastrointestinal: Diarrhea (8% to 15%)
1% to 10%:
Central nervous system: Headache (2%)
Dermatologic: Rash (≤3%)
Endocrine & metabolic: Bicarbonate decreased (≤1%), hyperglycemia (≤1%), hyperphosphatemia (≤1%)
Gastrointestinal: Nausea (≤3%), abdominal pain (≤1%), vomiting (≤1%)
Genitourinary: Vaginal moniliasis (≤4%), urine leukocytes increased (≤2%), urine pH increased (≤1%), urine specific gravity increased (≤1%), vaginitis (≤1%)
Hematologic: Lymphocytes increased (≤2%), eosinophils increased (1%), lymphocytes decreased (1%), platelets increased (≤1%), PMN changes (≤1%), WBC decreased/increased (≤1%)
Hepatic: Alkaline phosphatase increased (≤1%), ALT increased (≤1%)
Renal: Proteinuria (1% to 2%), microhematuria (≤1%), glycosuria (≤1%)
Miscellaneous: GGT increased (≤1%), lactate dehydrogenase increased (≤1%)
<1%, postmarketing, and/or case reports: Allergic vasculitis, amylase increased, anaphylaxis, anorexia, asthma, AST increased, bilirubin increased, bleeding tendency, bloody diarrhea, BUN increased, cardiac failure, chest pain, cholestasis, coagulation disorder, conjunctivitis, constipation, cutaneous moniliasis, disseminated intravascular coagulation (DIC), dizziness, dyspepsia, enterocolitis (acute), eosinophilic pneumonia, erythema multiforme, erythema nodosum, exfoliative dermatitis, facial edema, fever, flatulence, fulminant hepatitis, granulocytopenia, hemoglobin decreased, hemolytic anemia, hemorrhagic colitis, hepatic failure, hepatitis (acute), hyperkalemia, hyperkinesia, hypertension, hypocalcemia, hypophosphatemia, idiopathic thrombocytopenia purpura, ileus, insomnia, interstitial pneumonia (idiopathic), involuntary movement, jaundice, laryngeal edema, leukopenia, leukorrhea, loss of consciousness, maculopapular rash, melena, moniliasis, monocytes increased, myocardial infarction, nephropathy, pancytopenia, peptic ulcer, pneumonia (drug-induced), pruritus, pseudomembranous colitis, renal failure (acute), respiratory failure (acute), rhabdomyolysis, serum sickness, shock, somnolence, Stevens-Johnson syndrome, stomatitis, stools abnormal, thrombocytopenia, toxic epidermal necrolysis, upper GI bleed, urine specific gravity decreased, weakness, xerostomia
Additional reactions reported with other cephalosporins: Agranulocytosis, angioedema, aplastic anemia, asterixis, encephalopathy, hemorrhage, interstitial nephritis, neuromuscular excitability, PT prolonged, seizure, superinfection, and toxic nephropathy